(Medical Xpress)—In the ongoing quest to design new beneficial molecules or identify potential drugs catalogued in pharmaceutically databases, a critical requirement is determining how a ligand (typically a modulator, or ...
A study by chemists at the University of Chicago has uncovered a new key step in the process that HIV uses to replicate itself.
Jan 24, 2023
0
63
A large international team of researchers has conducted a study aimed at tracing the transmission rates and the origin of major SARS-CoV-2 strains currently circulating in Brazil. In their paper published in the journal Science, ...
This past weekend teams from the National Football League used statistics like height, weight and speed to draft the best college players, and in a few weeks, armchair enthusiasts will use similar measures to select players ...
Apr 29, 2013
0
0
Imagine tapping into the mind of a coma patient, or watching one's own dream on YouTube. With a cutting-edge blend of brain imaging and computer simulation, scientists at the University of California, Berkeley, are bringing ...
Sep 22, 2011
8
0
The anti-inflammatory drug celecoxib, known by the brand name Celebrex, triggers liver cancer cell death by reacting with a protein in a way that makes those cells commit suicide, according to a new study.
May 16, 2011
0
0
Using artificial intelligence (AI) to supplement radiologists' evaluations of mammograms may improve breast-cancer screening by reducing false positives without missing cases of cancer, according to a study by researchers ...
Apr 10, 2024
0
35
A spectrum of neurodegenerative diseases, including frontotemporal dementia (FTD), progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) are due to the accumulation of abnormal, misfolded tau proteins in ...
Apr 4, 2024
0
29
Researchers at EPFL reveal how Drosophila's Turandot proteins protect against immune self-harm. The study is the first to identify some proteins that protect against antimicrobial peptides offering insights into cellular ...
Mar 26, 2024
0
48
Researchers have shown for the first time that a crucial interface in a protein that drives cancer growth could act as a target for more effective treatments.
Mar 19, 2024
0
47
